RhoB Promotes Cancer Initiation by Protecting Keratinocytes from UVB-Induced Apoptosis but Limits Tumor Aggressiveness  by Meyer, Nicolas et al.
RhoB Promotes Cancer Initiation by Protecting
Keratinocytes from UVB-Induced Apoptosis but
Limits Tumor Aggressiveness
Nicolas Meyer1,2,3,7, Alexis Peyret-Lacombe1,2,7, Bruno Canguilhem1,2, Claire Me´dale-Giamarchi1,2,
Kenza Mamouni1,2, Agnese Cristini1,2, Sylvie Monferran1,2, Laurence Lamant1,2,4, Thomas Filleron5,
Anne Pradines1,2,6, Olivier Sordet1,2 and Gilles Favre1,2,6
The role of UVB-induced apoptosis in the formation of squamous cell carcinoma (SCC) is recognized. We
previously identified the small RhoB (Ras homolog gene family, member B) GTPase, an early response gene to
cellular stress, as a critical protein controlling apoptosis of human keratinocytes after UVB exposure. Here we
generated SKH1 (hairless immunocompetent mouse) mice invalidated for RhoB to evaluate its role in UVB-
induced skin carcinogenesis in vivo. We show that rhob / mice have a lower risk of developing UVB-induced
keratotic tumors and actinic keratosis that is associated with a higher sensitivity of UVB-exposed keratinocytes to
apoptosis. We extend this observation to primary cultures of normal human keratinocytes in which RhoB was
downregulated with small interfering RNA (siRNA) and further show that the hypersensitivity to apoptosis
depends on B-cell lymphoma 2 (Bcl-2) downregulation. In rhob / mice, the UVB-induced tumors were
preferentially undifferentiated and highly proliferative. Finally, we show in humans an almost constant loss of
RhoB expression in undifferentiated SCCs. These undifferentiated and RhoB-deficient tumors have elevated
phosphorylated histone H2AX (gH2AX) and 53BP1, two markers of DNA double-strand breaks. Together, our
results indicate that UVB-induced RhoB expression participates in in vivo SCC initiation by increasing
keratinocyte survival. Conversely, RhoB may limit tumor aggressiveness as loss of RhoB expression in tumor
cells is associated with tumor progression.
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INTRODUCTION
Cutaneous squamous cell carcinomas (SCCs) represent one of
the most common human cancer type (Madan et al., 2010).
Approximately 85% of SCCs are cured by surgery, whereas the
remaining 15% display poor prognosis. Currently, there are no
specific markers to predict tumor aggressiveness and risk of
recurrence in patients.
It is largely admitted that UVB plays a crucial role in the
development of SCC (Goodwin et al., 2004). The response of
keratinocytes to UVB is complex and depends upon a
balance between cell death and survival pathways.
Deregulation of genes controlling this balance is considered
as a key factor in the early phases of photocarcinogenesis
(De Gruijl and Voskamp, 2009). We previously identified
the GTPase RhoB (Ras homolog gene family, member B)
as a key regulator of the apoptotic response of human
HaCaT keratinocytes to UVB. We demonstrated that RhoB is
critical for EGFR-induced cell survival after UVB exposure
through regulation of Ak thymoma (AKT) phosphorylation
(Canguilhem et al., 2005).
RhoB belongs to the Rho GTPase family, a group of proteins
controlling many cellular functions such as cell survival and
migration, the deregulation of which are implicated in cancer
initiation and progression (Karlsson et al., 2009). rhob is an
early inducible gene activated by cellular stress including
hypoxia (Skuli et al., 2006), ionizing radiation (Milia et al.,
2005; Monferran et al., 2008), cytotoxic agents (Liu et al.,
2001), and UV irradiation (Fritz and Kaina, 2001; Canguilhem
et al., 2005). When activated, RhoB triggers a signaling
cascade promoting the activation of AKT and NF-kB survival
pathways (Mazie`res et al., 2005). Moreover, RhoB displays
tumor-suppressor gene functions in many cell types as well
as in mouse models (Chen et al., 2000; Liu et al., 2001;
Prendergast, 2001; Jiang et al., 2004). RhoB expression
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decreases during the progression of various tumors. Loss of
RhoB expression was shown to promote cell proliferation,
invasion, and metastasis.
Here, we develop hairless immunocompetent mice
(SKH1) invalidated for rhob to study its in vivo role in
UVB-induced photocarcinogenesis in mice. We also
evaluated the relevance of RhoB in humans using primary
cultures of human keratinocytes and human SCC tumor
samples. Altogether, our work emphasizes the critical
role of RhoB in both the initiation and the progression of
skin SCC.
RESULTS
rhob / mice experience a lower incidence of SCC precursor
tumors following chronic exposure to UVB
To evaluate in vivo the influence of RhoB on UVB-induced
skin carcinogenesis, we crossed the SKH1 mouse that mimics
UVB-induced photocarcinogenesis in humans (De Gruijl and
Forbes, 1995; Benavides et al., 2009; Sharma et al., 2011)
with rhob knockout (rhob / ) mice (Liu et al., 2001). The
SKH1 mice rhob / , rhobþ / , and rhobþ /þ were
exposed daily to 0.1 J cm 2 UVB, corresponding to one
minimal erythemal dose. Animals started to develop actinic
keratosis (AK)–like lesions after 12 weeks of chronic UVB
exposure and all mice exhibited at least one AK at 24 weeks.
AKs are precursors of SCC (Salasche, 2000). Mice also
developed small keratotic and large ulcerated tumors that
have a similar appearance to human SCC (De Gruijl and
Forbes, 1995). Notably, the relative distribution of AKs and
tumors varied, with mice developing primarily numerous AKs
together with a prevalence of small keratotic tumors, whereas
others only few AKs with primarily large ulcerated tumors
(Supplementary Figure S1 online).
The primary assessment of the extent of AKs in mice was
performed after 17 weeks of daily UVB exposure. Animals
were categorized as highly sensitive to UVB-induced photo-
carcinogenesis if they had AKs covering 450% of the dorsal
skin (group A). Animals experiencing o50% of their dorsal
skin covered by AKs were included in the low sensitivity
(group B; Figure 1a and Supplementary Figure S1 online; also
see Materials and Methods). Figure 1b shows that the mice
with high sensitivity to UVB-induced photocarcinogenesis
were almost exclusively the þ /þ and þ / rhob mice,
whereas mice presenting lower sensitivity were mainly
rhob / . In rhob / mice, the lower occurrence of AKs
was associated with a reduced total number of skin tumors
(Figure 1c and Supplementary Figure S2 online). These results
were confirmed in a second set of experiments (Supple-
mentary Figure S3a and b online). Analysis of the tumor type
revealed that small keratotic tumors were less prevalent in
rhob / mice (Figure 1d and Supplementary Figure S4a
online), whereas the prevalence of large ulcerated tumors was
not significantly different in rhobþ /þ and rhob / mice
(Figure 1e). We concluded that the absence of RhoB is
associated with a reduction in the occurrence of AKs and
small keratotic tumors upon chronic exposure to UVB without
significantly affecting the induction of large ulcerated tumors
(Supplementary Figure S4b online).
UVB irradiation induces RhoB expression in normal human skin
tissues
Because SCCs develop from the stratum spinosum in response
to UVB (Ratushny et al., 2012), we analyzed RhoB expression in
the human epidermis. After surgical excision, human skin tissues
from two healthy donors were left untreated or exposed to
0.4 J cm2 UVB. At 8hours after irradiation, expression of RhoB
was analyzed by immunohistochemistry (Figure 2a and b and
Supplementary Figure S5 online). In the absence of treatment,
RhoB was expressed at very low levels at the suprabasal layers
of the epidermis and was mostly detected at the basal layer
(Figure 2a and b). Keratinocytes from the basal layer are the
replicating cells ensuring renewal of suprabasal layers. Follow-
ing UVB exposure, RhoB expression was markedly increased at
the suprabasal layers of the epidermis (Figure 2b). Altogether,
these results suggest that the induction of RhoB at the suprabasal
layers of the epidermis in response to UVB may be involved in
the development of AKs and small keratotic tumors.
Keratinocytes of rhob / mice are hypersensitive to
UVB-induced apoptosis
To gain insight into the mechanism of RhoB-induced skin
carcinogenesis, we analyzed the role of RhoB in the apoptotic
response to UVB. Apoptosis is a major anticancer
barrier (Lowe and Lin, 2000; Wong, 2011). We have
previously shown that knocking down RhoB in human
HaCaT cells confers hypersensitivity to UVB-induced apop-
tosis (Canguilhem et al., 2005). It is also clearly demonstrated
that RhoB is involved in the apoptotic response to genotoxics,
including ionizing radiation (Fritz and Kaina, 2001; Liu et al.,
2001; Jiang et al., 2004; Milia et al., 2005). To test whether
the reduced number of AKs and small keratotic tumors in
rhob / mice could be related to an excess of apoptosis,
we compared UVB-induced apoptosis of rhobþ /þ and
rhob / mice keratinocytes. Mice were exposed to
0.2 J cm2 UVB and apoptotic DNA fragmentation was
assessed 24 hours later by TUNEL assay (Samejima and
Earnshaw, 2005) on formalin-fixed, paraffin-embedded
(FFPE) skin samples by microscopy. Figure 3a shows that
the percentage of TUNEL-positive keratinocytes was signifi-
cantly higher in rhob / mice than in rhobþ /þ mice.
We also tested whether tumoral keratinocytes of rhob /
mice were more sensitive to UVB-induced apoptosis. All FFPE
tumor samples collected after chronic UVB exposure of
rhobþ /þ (n¼17) and rhob / (n¼23) mice were
assessed for apoptosis by cleaved caspase-3 immunostaining
(Supplementary Figure S6 online). A significantly higher
proportion of cleaved caspase-3-positive keratinocytes was
found in rhob / mice tumors compared with rhobþ /þ
mice tumors (Figure 3b). Together, these results indicate that
RhoB deficiency confers hypersensitivity of both normal and
tumoral keratinocytes to UVB-induced apoptosis, which could
protect rhob / mice against UVB-induced tumor initiation.
RhoB protects human keratinocytes from UVB-induced
apoptosis through Bax/Bcl-2 ratio modulation
To determine whether these results could be extended to
humans, we isolated normal human keratinocytes (NHKs)
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from healthy donors. RhoB expression was downregulated by
transient transfection with small interfering RNA (siRNA)
duplexes. Then, cells were exposed to 0.4 J cm 2 UVB and
apoptosis was assessed after 24 hours. The siRNA-mediated
depletion of RhoB in human NHK (Supplementary Figure S7
online) resulted in marked increase of cleaved caspase-3
(Figure 3c), caspase-3-dependent cleavage of poly (ADP-
ribose) polymerase (Figure 3d), and apoptotic DNA fragmen-
tation (Figure 3e).
It has been demonstrated that the Bax/B-cell lymphoma 2
(Bcl-2) ratio, a critical element determining cell death
or cell survival, increases after UVB exposure in HaCaT
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Figure 1. The rhob / mice develop fewer skin tumors after chronic exposure to UVB. The rhobþ /þ , rhobþ / and rhob / mice were chronically
exposed to UVB (0.1 J cm 2). (a) Mice were separated into two groups according to the percentage of actinic keratoses (AKs) on the skin of their back at week 17:
group A (450%) and group B (o50%). (b) Percentage of mice of the two groups according to their genotype. (c) Number of tumors (keratotic, ulcerated) per
mouse at the indicated times (meanþ SD). AK lesions were excluded. (d) Number of keratotic tumors at the indicated times (meanþ SD). (e) Number of ulcerated
tumors per mouse after 22 weeks (meanþ SD). Examples of AK and tumors (keratotic, ulcerated) are presented in Supplementary Figure S1 online. P-values are
calculated as described in the Statistical Analysis section of the Materials and Methods.
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(Reagan-Shaw et al., 2006) and NHK cells (Afaq et al., 2007).
UVB irradiation (0.4 J cm2) of NHKs increased Bax expres-
sion and decreased Bcl-2 expression, causing a 3-fold increase
in the Bax/Bcl-2 ratio after 24 hours (Figure 4a and b).
Under these conditions, RhoB downregulation with siRNA
further decreased Bcl-2 expression without changing Bax
expression (Figure 4a and b), leading to a 15-fold increase
in the Bax/Bcl-2 ratio.
Because Bcl-2 expression can be regulated by many
survival proteins including AKT (Maddika et al., 2007), we
investigated the role of RhoB on AKT phosphorylation/
activation in NHKs exposed to UVB. Figure 4c shows that
RhoB downregulation with siRNA prevented UVB-induced
AKT phosphorylation on serine 473 after 4 and 8 hours.
This was associated with a reduction of Bcl-2 expression
(Figure 4c). These data suggest that RhoB favors NHK survival
after UVB through upregulation of the AKT/Bcl-2 pathway,
leading to a decrease in the Bax/Bcl-2 ratio. It is unlikely that
the protective effect of RhoB on apoptosis could be related to
p53 because its expression was not affected in both
RhoB-deficient cells (Supplementary Figure S8a online) and
RhoB- deficient mouse tumors (Supplementary Figure S8b
online). Moreover, p53 and RhoB expressions were not
correlated in human tumors (Supplementary Table S1 online).
RhoB loss is associated with the preferential induction of
undifferentiated tumors
Tumor differentiation is inversely related to tumor progression
and metastatic potential. Undifferentiated tumors frequently
display a higher proliferative and invasive potential (Spector
et al., 2011). To evaluate the levels of differentiation of
individual tumors from rhobþ /þ and rhob / mice, all
FFPE tumor samples collected after chronic exposure were
divided into two categories as exemplified in Figure 5a: mild-
to-well-differentiated tumors were defined as tumors with
organoid differentiation without significant cytokeratin-8
expression, whereas low-differentiated to undifferentiated
tumors were tumors without organoid differentiation and
without significant cytokeratin-1 expression. Figure 5b
shows that the proportion of low-to-undifferentiated
tumors was higher in rhob / than in rhobþ /þ mice.
Tumors from rhob / mice showed a higher proportion of
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Figure 2. RhoB (Ras homolog gene family, member B) is induced in human healthy skin explants after UVB exposure. (a) RhoB immunostaining on human
healthy skin explant. The expression of RhoB is weak and mainly localized in basal layer keratinocytes. (b) RhoB immunostaining on human skin explants from
two healthy donors (scale¼ 20mm), unirradiated or 8 hours after 0.4 J cm2 UVB irradiation. The expression of RhoB is markedly increased and detectable in the
entire epidermis.
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cells positive for the proliferation marker Ki67 (Figure 5c)
(Batinac et al., 2006). These results are in agreement with
rhob / mice developing less small keratotic tumors
(Figure 1d), which are normally more differentiated than
ulcerated tumors, and suggest that RhoB deficiency increases
tumor aggressiveness.
We then analyzed RhoB expression in individual tumors
from rhobþ /þ mice, depending on their differentiation
grade. Reverse transcriptase–quantitative PCR analyses
revealed that levels of RhoB transcripts were markedly
reduced in mildly differentiated tumors as compared with
well-differentiated tumors (Figure 5d), suggesting that RhoB
expression decreases during progression of skin tumors upon
chronic UVB exposure. Although we demonstrated that
oncogenic ras mutants downregulated RhoB expression in
lung tumors (Bousquet et al., 2009), we did not find
any mutations in H-ras, N-ras, and K-ras genes in rhobþ /þ
and rhob / mice SCCs.
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Figure 3. Keratinocytes deficient for RhoB (Ras homolog gene family, member B) are hypersensitive to UVB-induced apoptosis. (a) Mice of the indicated
genotype were exposed to a single UVB dose (0.2 J cm2). TUNEL staining. Epidermis (ED) and dermis (D) are separated by the dotted white line (scale¼5mm).
Graph represents the percentage of TUNEL-positive cells in the epidermis (meanþ SD; two fields per slide; from 71 to 244 cells per field). (b) Percentage of cleaved
caspase-3 in UVB-induced mice tumors (meanþ SD; two fields per slide; from 199 to 584 cells per field). (c, d) Normal human keratinocytes (NHKs) were exposed
to UVB (0.4 J cm 2) and analyzed 24 hours later. (c) Percentage of cleaved caspase-3-positive NHKs (meanþ SD). (d) PARP (poly (ADP-ribose) polymerase)
cleavage. (e) NHKs plated on coverslip were exposed to UVB (0.4 J cm 2) and then stained for 40,6-diamidino-2-phenylindole (DAPI) and TUNEL 16 hours after
exposure. Ctrl, control; si, small interfering RNA.
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RhoB loss is associated with increased levels of DNA
double-strand breaks
To determine whether these results could be extended to
humans, we analyzed RhoB expression on human invasive
SCC by immunohistochemistry and microscopy. A total of
80 tumor samples were selected according to their level of
differentiation (as described above for mice tumors) in the
tumor bank of Toulouse-Purpan Hospital. Two groups were
constituted: the first group with 40 well-differentiated SCCs,
and the second one with 40 undifferentiated SCCs. We
observed that almost all undifferentiated human SCCs did not
express RhoB (Figure 6a and Supplementary Figure S9 online).
On these human tumor samples, we also analyzed the
expression of phosphorylated histone H2AX (referred to as
gH2AX), a marker for DNA double-strand breaks (DSBs)
(Bonner et al., 2008). DSBs are severe lesions and their
inefficient/inaccurate repair can contribute to genomic
instability and cancer progression (Bonner et al., 2008).
Figure 6b shows that the undifferentiated and RhoB-deficient
human skin tumors have elevated gH2AX expression; RhoB
and gH2AX expression were inversely correlated (Spearman’s
r ¼ 0.50; 95% confidence interval: 0.77 to  0.06).
Besides gH2AX, we analyzed p53 binding protein 1 (53BP1),
another DNA damage response protein that accumulates at
sites of DSBs (Lukas et al., 2011). Figure 6c shows that
undifferentiated human skin tumors have elevated expression
of 53BP1. Consistent with these results, tumors from
rhob / mice show elevated gH2AX- and 53BP1-positive
cells compared with tumors from rhobþ /þ mice (Figure 6d
and 6e and Supplementary Figure S10a, b online). These
results suggest that loss of RhoB expression increases the levels
of endogenous DSBs. To test more directly this hypothesis, we
compared gH2AX expression of rhobþ /þ and rhob /
basal layer keratinocytes from normal skin tissues. We
observed a significant increase of gH2AX labeling in kerati-
nocytes from rhob / mice (Figure 6f and Supplementary
Figure S10c online). Immunofluorescence microscopy experi-
ments further show that gH2AX-positive cells from rhob /
skin tissues were also positive for 53BP1 (Figure 6g). Because
rhobþ /þ and rhob / cells have similar proliferation rate
(Supplementary Figure S11 online), it is unlikely that the
increase of gH2AX in rhob / skin tissues simply resulted
from increased DNA replication. Together, these results
indicate that RhoB deficiency is accompanied with increased
levels of DSBs, suggesting that loss of RhoB expression might
contribute to genomic instability and skin tumor progression.
DISCUSSION
This study provides insights, which to our knowledge are
previously unreported, in the understanding of UVB-induced
keratinocyte carcinogenesis in vivo, emphasizing the role of
RhoB. We demonstrate that UVB-induced RhoB expression
participates in maintaining cell survival, thus favoring the
development of SCCs. Our data clearly show that keratino-
cytes from RhoB-deficient mice are more sensitive to UVB-
induced apoptosis and that these mice develop fewer AKs and
keratotic tumors than the wild-type counterparts. These results
are consistent with our previous work showing that RhoB
downregulation sensitized HaCaT immortalized keratinocytes
to UVB-induced apoptosis (Canguilhem et al., 2005). We
further extended these observations to human keratinocytes
isolated from the skin of healthy donors. In addition, we show
that basal expression of RhoB in human skin is almost only
detectable in keratinocytes from the basal layer, and that UVB
exposure induces a strong holoepidermic expression of RhoB.
Together, these observations support the possibility that UVB-
induced RhoB expression protects UVB-exposed keratino-
cytes from apoptosis, thereby promoting the initiation of
carcinogenesis. RhoB may protect keratinocytes from UVB-
induced apoptosis by activating cell survival pathways.
Indeed, we have previously demonstrated that UVB-induced
EGFR survival pathway depends on RhoB in HaCaT cells
through regulation of AKT phosphorylation (Canguilhem et al.,
2005). Increased Bcl-2 expression has been reported to favor
photocarcinogenesis by preventing apoptosis (Nakagawa
et al., 1994; Delehedde et al., 1999). We demonstrate here
that RhoB is a critical determinant for Bcl-2 expression after
Ctrl Ctrlsi l si 2 si l si 2 Ctrl si l
UVB + 24 hoursUVB + 8 hoursUntreated
si 2 si RhoB
Bax
Bcl-2
P <0.01
P <0.01
P <0.01
P <0.001Control siRNA
20
15
10
5
0
0 8
Hours after UVB irradiation
UVB + 4 hours UVB + 8 hoursUntreated
Ctrl si 1 si 2 Ctrl si 1 si 2 Ctrl si 1 si 2 si RhoB
p-AKT (ser
472/473/474)
AKT
Bcl-2
24
si RhoB 1
si RhoB 2
Ba
x/
Bc
l-2
 ra
tio
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modulation. (a) Normal human keratinocytes (NHKs) were treated with small
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UVB exposure (Figure 4) and therefore suggest that the RhoB/
Bcl-2 axis is involved in early phase of UVB-induced
carcinogenesis.
RhoB also participates in the control of skin tumor
progression. This is supported by three lines of evidence: (1)
rhob / mice are prone to the development of UVB-
induced aggressive SCCs, (2) in rhobþ /þ mice exposed to
UVB, RhoB expression is downregulated in poorly differen-
tiated and thereby aggressive SCCs (Figure 5d), and (3) RhoB
expression is also selectively lost in undifferentiated human
skin tumors (Figure 6a). Moreover, because the number of
ulcerated tumors is similar in the rhobþ /þ and rhob /
genotypes (Figure 1e), it is likely that RhoB does not prevent
the occurrence of undifferentiated tumors. This is in agreement
with our hypothesis that tumor progression requires loss of
RhoB expression. These results are in agreement with our
previous work on lung cancer showing that loss of RhoB
occurs in the most aggressive tumors (Mazieres et al., 2004)
and promotes invasion of human bronchial cancer cells
(Bousquet et al., 2009). Consistently, Adnane et al (2002).
reported loss of RhoB expression in invasive human SCCs of
the head and neck. Although the tumor-suppressor role of
RhoB is now well documented, its mechanism remains to be
elucidated. Our experiments indicate that RhoB-deficient cells
have elevated endogenous DSBs (Figure 6), and therefore
suggest that loss of RhoB expression during progression of skin
tumors (this study) and potentially the above-mentioned
tumors (Adnane et al., 2002; Mazieres et al., 2004;
Bousquet et al., 2009) could promote oncogenesis by
increasing DSB-mediated genomic instability. Further studies
will be required to determine the molecular mechanisms by
which loss of RhoB enhances endogenous DSBs.
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Our results support the hypothesis that RhoB plays a
double-edged role in oncogenesis. Beside its role as a
negative regulator of tumor progression, we report here
a new aspect of the role of RhoB in skin oncogenesis in
promoting tumor initiation through survival of UVB-exposed
cells. RhoB could favor early stages of oncogenesis but
at the same time could limit tumor aggressiveness. In this
model, alteration of gene expression leading to RhoB down-
regulation would then become necessary for tumor progres-
sion. These results are in agreement with our previous
report on lung cancer (Mazieres et al., 2004), in which we
observed the expression of RhoB in in situ carcinoma of
the lung and subsequent loss of RhoB expression in invasive
cancers.
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Figure 6. RhoB (Ras homolog gene family, member B) loss is associated with increased levels of DNA double-strand breaks. (a) RhoB immunostaining on human
squamous cell carcinomas (SCCs). Graph shows the proportion of tumors expressing RhoB depending on the level of differentiation. Diff., differentiated; Undiff.,
undifferentiated. (b) Phosphorylated histone H2AX (gH2AX) immunostaining on human SCCs (scale¼5mm). Graph shows the percentage of gH2AX-positive cells
depending on the level of differentiation (meanþ SD). (c) The 53BP1 immunostaining on human SCCs (scale¼ 5mm). Graph shows the percentage of positive cells
depending on the level of differentiation (meanþ SD). Percentages of (d) gH2AX-positive cells and (e) 53BP1-positive cells in mouse tumors depending on rhob
genotype (meanþ SD). (f) Proportion of gH2AX-positive keratinocytes in the epidermal basal layer (meanþ SD). (g) gH2AX and 53BP1 dual staining on rhob /
mouse healthy skin, confocal imaging.
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Understanding the role of RhoB in photocarcinogenesis
could help to find novel strategies into routine clinical
practice for the 15% of human SCCs displaying poor
prognosis. Indeed, our results suggest that loss of RhoB
may be considered a negative prognostic marker of
human SCCs of the skin. Further studies are needed
to assess the prognostic value of RhoB expression on large
cohorts of patients with SCCs. Deciphering the RhoB
pathway involved in the control of skin photocarcinogenesis
may help the development of new therapeutic strategies
against SCCs.
In conclusion, our results show that RhoB is a critical
determinant for SCC initiation and that loss of RhoB
expression in SCCs may predict tumor aggressiveness.
MATERIALS AND METHODS
Mice
SKH1 mice (Charles River, L’Arbresle, France) were crossed with
Sv129/rhob / mice (Supplementary Figure S1 online) (Liu et al.,
2001). The Claudius Regaud Institute animal ethic committee
approval (no. ICR-2009-016) was obtained for the use of the animal
model and the study protocols.
UV exposure
Protocols of mice and cells UVB exposure are described in
Supplementary Materials and Methods online.
Definition of the UV-induced phenotypes
A clinical evaluation of the mice at week 17 was performed on
standardized photographs. Mice were separated in two groups
according to the extent (4 or o50%) of UV-induced AK on the
dorsal skin defined as the skin between the base of the neck and the
base of the tail (Figure 1a and Supplementary Figure S1 online). The
17-week UVB exposure end point for assessment of the effect of UVB
on the occurrence of SCC precursors was chosen as the latest time at
which all mice were alive. No consensus definition exists on the
severity categorization of AK in humans or mice. The threshold of
50% for AK coverage of the dorsal skin of mice was chosen as an
indicator of high UVB-induced skin damage.
NHK culture and siRNA transfection
NHK primary cultures were prepared from skin explants from patients
undergoing mammary plastic surgery (see Supplementary Materials
and Methods online). Transfection of NHKs by siRNAs (10 nM)
(described in Canguilhem et al., 2005) was performed using
Oligofectamine (Life Technologies SAS, Saint Aubin, France) in
keratinocyte serum-free medium according to the manufacturer’s
instructions on cells at 30–50% confluence in 60-mm cell culture
dishes and seeded 24 hours before experiments.
Immunoblot analysis
Immunoblot analysis of RhoB was performed as previously described
(Canguilhem et al., 2005), see Supplementary Materials and Methods
online.
Pathological examination of the tumors
FFPE mouse tumor samples were cut in 4-mm-thick sections. Sections
were incubated at 100 1C for 15 minutes and then deparaffinized with
xylene and rehydrated. Sections were stained with hematoxylin and
eosin, and read by a trained dermatopathologist.
Human SCCs of the skin
A total of 80 FFPE human SCCs were obtained from the tumor bank of
the department of pathology (Toulouse-Purpan Hospital, France) after
written informed consent. The specimens consisted of 40 mild-to-
well-differentiated and 40 low-to-undifferentiated invasive SCCs of
the skin.
Immunostaining of tissues
Immunostainings were performed as described in Supplementary
Materials and Methods online.
Immunofluorescent staining of tissues
Sections of cryoconserved tumor samples were fixed in 3% paraf-
ormaldehyde and permeabilized with 0.1% Triton X-100. After a
saturation step in 3% BSA/phosphate-buffered saline, cells were
incubated with mAb against gH2AX (9718, Cell Signaling, Danvers,
MA) and then with Alexa Fluor 488 antibody (Life Technologies SAS).
Coverslips were mounted on slides with Mowiol solution containing
40,6-diamidino-2-phenylindole. Staining was detected by fluores-
cence microscopy.
Flow cytometry analyses of cleaved caspase-3 in NHKs
The phycoerythrin-conjugated Polyclonal Active Caspase-3 Antibody
Apoptosis Kit (BD Pharmingen, Franklin Lakes, NJ) was used accord-
ing to the manufacturer’s instructions. Fluorescence was analyzed by
flow cytometry on a BD-FACS Calibur (Le Pont de Claix, France).
Quantitative reverse transcribed–PCR
Flash-frozen tissue (50 mg) was homogenized in a TissueLyser system
(Qiagen, Courtaboeuf, France). RNA was isolated using miRNeasy kit
following the manufacturer’s instructions (Qiagen) and reverse tran-
scribed using iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA).
Quantitative PCR was performed with a CFx-96 real-time system
(Bio-Rad). The specific murine primer pairs are described in
Supplementary Materials and Methods online.
Statistical analysis
Comparisons of percentages were made using the w2 test. For mean
comparisons between groups the two-sample t-test and the Mann–
Whitney test were used as appropriate. The Kaplan–Meier method
was used to estimate the distribution time taken to reach 10 tumors or
5 keratotic tumors, and differences among the groups were tested by
the log-rank test. All tests were two sided with an a risk of 5%.
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